title: Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities.
authors.affiliation: Clinical Neurosciences, School of Molecular and Clinical Medicine, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU, Scotland, UK. paul.armitage@ed.ac.uk
authors.forename: Paul A
authors.initials: PA
authors.lastname: Armitage
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Farrall
authors.forename: Trevor K
authors.initials: TK
authors.lastname: Carpenter
authors.forename: Fergus N
authors.initials: FN
authors.lastname: Doubal
authors.forename: Joanna M
authors.initials: JM
authors.lastname: Wardlaw
mesh_terms: D000368:Aged; D001812:Blood-Brain Barrier / Q000473:pathology*; D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D020521:Stroke / Q000473:pathology*
chemical_list: D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA